Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

ยฉ 2026 Go Backs. All rights reserved.

Medium RiskFDA Vet
Pets & Animals/Pet Medications

JD & SN Inc., dba Moses Lake Professional Pharmacy: Cyclosporin Eye Drops and Buprenorphine Recalled for Lack of Sterility

Agency Publication Date: November 6, 2015
Share:
Sign in to monitor this recall

Summary

Moses Lake Professional Pharmacy is recalling 80 mL of Cyclosporin 1% ophthalmic eye drops and 20 mL of Buprenorphine 0.3 mg/mL injectable solution for veterinary use. These compounded medications are being recalled because they lack assurance of sterility, which means the products may be contaminated with microorganisms. No injuries have been reported to date, but the products were dispensed or distributed in Oregon and Washington. Consumers should contact their veterinarian or the pharmacy immediately regarding these prescription products.

Risk

A lack of sterility assurance in medications intended for the eyes or by injection can lead to serious infections in animals. If the products contain bacteria or fungi, they can cause localized or systemic illness that may be difficult to treat.

What You Should Do

  1. Check your medication labels for Cyclosporin ophthalmic 1% drops with the following lot numbers: t09242014@14, t10062014@3, t10062014@29, t02032015@22, or t06252015@29.
  2. Check your medication vials for Buprenorphine 0.3mg/mL injectable solution with lot numbers: t03242015@21 or t06112015@37.
  3. Immediately stop using these medications for your pets if the lot numbers match the ones listed above.
  4. Contact your veterinarian or healthcare provider to discuss alternative treatments and to report any adverse health effects your animal may be experiencing.
  5. Contact Moses Lake Professional Pharmacy at 1555 Pilgrim St, Moses Lake, Washington, 98837-4623 for instructions on returning the product and obtaining a refund.
  6. For further questions or to report an issue, you may contact the FDA's Center for Veterinary Medicine at 1-240-402-7002.

Your Remedy Options

๐Ÿ’ฐFull Refund

Veterinary Drug Recall Refund

How to: Contact your healthcare provider or pharmacist for guidance. Return any unused product to the pharmacy for a refund

Affected Products

Product: Cyclosporin drops, ophthalmic 1% (80 mL)
Model:
Recall #: V-265-2016
Lot Numbers:
t09242014@14
t10062014@3
t10062014@29
t02032015@22
t06252015@29
Product: Buprenorphine injectable solution, 0.3mg/mL (20 mL)
Model:
Recall #: V-266-2016
Lot Numbers:
t03242015@21
t06112015@37

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 71802
Status: Resolved
Manufacturer: JD & SN Inc., dba Moses Lake Professional Pharmacy
Sold By: Moses Lake Professional Pharmacy
Manufactured In: United States
Units Affected: 2 products (80 mL; 20 mL)
Distributed To: Oregon, Washington

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES ยท Raw API Response